Get the Stockscreener App
6.53
2.19%
0.14
After Hours:
6.32
-0.21
-3.22%
Lifeward Ltd stock is traded at $6.53, with a volume of 16,666.
It is up +2.19% in the last 24 hours and up +8.47% over the past month.
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.
See More
Previous Close:
$6.39
Open:
$6.49
24h Volume:
16,666
Relative Volume:
0.63
Market Cap:
$9.98M
Revenue:
$22.03M
Net Income/Loss:
$-19.91M
P/E Ratio:
-0.3527
EPS:
-18.5136
Net Cash Flow:
$-16.84M
1W Performance:
-2.83%
1M Performance:
+8.47%
6M Performance:
-30.40%
1Y Performance:
-70.26%
1-Day Range:
$6.16
$6.625
1-Week Range:
$5.96
$6.98
52-Week Range:
$4.14
$23.04
Lifeward Ltd Stock (LFWD) Company Profile
Name
Lifeward Ltd
Sector
Industry
Phone
15082511154
Address
200 DONALD LYNCH BLVD., MARLBOROUGH
Compare LFWD vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LFWD
Lifeward Ltd
|
6.53 | 9.77M | 22.03M | -19.91M | -16.84M | -18.51 |
ABT
Abbott Laboratories
|
104.83 | 180.82B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.65 | 125.72B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.89 | 111.16B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.78 | 101.28B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.67 | 47.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Lifeward Ltd Stock (LFWD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-10-25 | Initiated | Laidlaw | Buy |
| Apr-03-17 | Downgrade | Barclays | Equal Weight → Underweight |
| Dec-16-16 | Initiated | Oppenheimer | Outperform |
| Jul-15-16 | Initiated | Piper Jaffray | Overweight |
| May-22-15 | Upgrade | Canaccord Genuity | Hold → Buy |
| May-08-15 | Reiterated | Barclays | Equal Weight |
| Oct-07-14 | Initiated | Barclays | Equal Weight |
View All
Lifeward Ltd Stock (LFWD) Latest News
Lifeward Completes Oratech Acquisition and Secures Private Financing - TipRanks
Lifeward closes Oramed partnership, secures $10 million funding - Investing.com
Lifeward (NASDAQ: LFWD) closes Oratech buy with new shares and $10M notes - Stock Titan
Lifeward Successfully Closes on Strategic Partnership with Oramed - GlobeNewswire
Insider Sell: Is Lifeward Ltd affected by consumer sentiment2026 Decliners & Target Return Focused Stock Picks - baoquankhu1.vn
Lifeward shares fall after Q4 results miss expectations - MSN
If You Invested $1,000 in Lifeward Ltd (LFWD) - Stock Titan
Lifeward Faces Nasdaq Audit Committee Compliance Challenge - The Globe and Mail
Aug Levels: Is Lifeward Ltd a speculative investmentQuarterly Market Summary & Weekly High Return Stock Forecasts - baoquankhu1.vn
Lifeward Ltd. Files Form 8-K with SEC – Key Company Information and Filing Details for March 2026 - Minichart
Lifeward Shares Rise 5.1% on Expanded Distribution Deal in UAE and GCC - MSN
Lifeward Received Notice of Noncompliance - TradingView
Audit committee shortfall puts Lifeward (NASDAQ: LFWD) on Nasdaq non-compliance notice - Stock Titan
LFWD Stock: HC Wainwright & Co. Raises Price Target to $10.00 | - GuruFocus
Lifeward stock price target raised to $10 on partnership strength By Investing.com - Investing.com Canada
Risk Report: Will Lifeward Ltd stock hit new highs in YEARPortfolio Update Summary & High Return Trade Guides - baoquankhu1.vn
Lifeward stock price target raised to $10 on partnership strength - Investing.com UK
Lifeward reports net loss of USD 5.3M in Q4 2025 - Medical Buyer
Rewalk Robotics Ltd receives Investment Bank Analyst Rating Update By Investing.com - Investing.com
Lifeward Ltd (LFWD) Q4 2025 Earnings Call Highlights: Strategic Moves and Market Challenges - GuruFocus
Lifeward Ltd. Announces Strategic Expansion, Acquisition of Exoskeleton Technology, and Improved 2025 Financial Results - Minichart
Lifeward Ltd’s 2025 Earnings Call: Revenue Miss, Medicare Pipeline Discrepancies, and Timelines Clash - Bitget
Lifeward 2025 10-K: Revenue $22.0M, Gross Profit $8.4M - TradingView
Lifeward (LFWD) expands neurorehab platform with Oramed deal and Medicare gains - Stock Titan
Lifeward (LFWD) Pursues Growth with New Strategic Partnership - GuruFocus
Lifeward (LFWD) 2025 Financials: Q4 Revenue $5.1M, Annual Loss $19.9MNews and Statistics - IndexBox
Lifeward: Overview of Fourth Quarter Financial Results - Bitget
Lifeward Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Lifeward Ltd reports results for the quarter ended December 31Earnings Summary - TradingView
LFWD: 2025 revenue fell 14%, but ReWalk unit sales rose 22% and gross margin improved - TradingView
Earnings call transcript: Lifeward Q4 2025 earnings reveal significant shortfall - Investing.com
Lifeward posts Q4 revenue $5.1M, FY2025 revenue $22.0M; net loss narrows to $19.9M - TradingView
LFWD: Strategic shift and new partnerships drive innovation, efficiency, and expanded market access - TradingView
Lifeward: Q4 Earnings Snapshot - WKYC
Oramed deal reshapes Lifeward (NASDAQ: LFWD) with new tech and funding - Stock Titan
Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
Press Release: Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results - 富途牛牛
Lifeward Q4 2025 Earnings Call Transcript - MarketBeat
Geopolitics Watch: Is Lifeward Ltd forming bullish engulfing patterns2026 Market WrapUp & AI Powered Market Trend Analysis - baoquankhu1.vn
Lifeward Ltd (LFWD) Q4 2025: Everything You Need To Know Ahead O - GuruFocus
Short Covering: Can Lifeward Ltd maintain sales growth2026 Intraday Action & Weekly Sector Rotation Insights - baoquankhu1.vn
Lifeward Ltd. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Lifeward regains Nasdaq minimum bid price compliance By Investing.com - Investing.com Nigeria
Lifeward Shareholders Approve Oratech Deal and Governance Changes - The Globe and Mail
Lifeward shareholders approve Oramed partnership deal By Investing.com - Investing.com India
LFWD SEC FilingsLifeward Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Lifeward shareholders approve Oratech acquisition and board changes By Investing.com - Investing.com South Africa
Lifeward shareholders approve Oratech acquisition and board changes - Investing.com Nigeria
Lifeward Ltd Stock (LFWD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):